Poplar Forest Capital’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,149
Closed -$321K 55
2019
Q2
$321K Hold
3,149
0.02% 54
2019
Q1
$283K Buy
3,149
+29
+0.9% +$2.51K 0.02% 56
2018
Q4
$260K Buy
3,120
+400
+15% +$37.5K 0.02% 57
2018
Q3
$294K Buy
+2,720
New +$298K 0.02% 61
2016
Q3
Sell
-598,860
Closed -$48.8M 52
2016
Q2
$48.8M Sell
598,860
-68,221
-10% -$5.19M 4.54% 5
2016
Q1
$47.7M Sell
667,081
-19,710
-3% -$1.32M 4.15% 4
2015
Q4
$48.9M Sell
686,791
-11,480
-2% -$772K 4.34% 4
2015
Q3
$42.9M Sell
698,271
-46,558
-6% -$3.25M 3.99% 12
2015
Q2
$54M Sell
744,829
-152,052
-17% -$11.2M 4.09% 8
2015
Q1
$68.9M Buy
896,881
+108,197
+14% +$7.75M 5.04% 1
2014
Q4
$52.9M Buy
788,684
+186,100
+31% +$11.7M 4.39% 5
2014
Q3
$36.6M Buy
602,584
+440,407
+272% +$27.1M 3.24% 12
2014
Q2
$9.52M Buy
+162,177
New +$9.5M 0.95% 32

Other funds holding DGX

Poplar Forest Capital's DGX Position: Q3 2019 in Review

Poplar Forest Capital sold out of Quest Diagnostics (DGX) in Q3 2019, closing a stake of 3,149 shares — an estimated $321K sold.

Poplar Forest Capital first reported a position in DGX in Q2 2014 and held it in 13 quarters. The position peaked at $68.9M in Q1 2015. 676 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

  • Poplar Forest Capital reported no remaining Quest Diagnostics position as of Q3 2019 after selling out during the quarter.
  • Poplar Forest Capital sold 3,149 Quest Diagnostics shares in Q3 2019, an estimated $321K.
  • Poplar Forest Capital first reported a position in Quest Diagnostics in Q2 2014 and held it in 13 quarters.
  • Poplar Forest Capital's Quest Diagnostics position peaked at $68.9M in Q1 2015.
  • 676 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Poplar Forest Capital's 13F filing for Q3 2019, filed 1 Nov 2019.